Longitudinal changes in sputum and blood inflammatory mediators during FeNO suppression testing:

Simon Couillard, Rahul Shrimanker, Samuel Lemaire-Paquette, Gareth M Hynes, Catherine Borg, Clare Connolly, Samantha Jane Thulborn, Angela Moran, Sarah Poole, Sophie Morgan, Timothy Powell, Ian Pavord, Timothy Hinks

8 July, 2022

NZ Respiratory Research Review Issue 200

‘Breathing Fire’: Impact of Prolonged Bushfire Smoke Exposure in People with Severe Asthma:

Beyene et al.

16 June, 2022

NZ Respiratory Research Review Issue 200

Using a knowledge translation framework to identify health care professionals’ perceived barriers and enablers for personalised severe asthma care:

Eleanor C. Majellano,Vanessa L. Clark,Rebecca F. McLoughlin,Peter G. Gibson,Vanessa M. McDonald

7 June, 2022

NZ Respiratory Research Review Issue 200

Violence-related distress and lung function in two longitudinal studies of youth:

Kristina Gaietto, Yueh-Ying Han, Erick Forno, Leonard B. Bacharier, Wanda Phipatanakul, Theresa W. Guilbert, Michael D. Cabana, Kristie Ross, Joshua Blatter, Edna Acosta-Pérez, Gregory E. Miller, Rafael E. de la Hoz, Franziska J. Rosser, Sandy Durrani, Glorisa Canino, Stephen R. Wisniewski, Juan C. Celedón

12 May, 2022

NZ Respiratory Research Review Issue 200

Short-acting β2-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study:

Eric D. Bateman, David B. Price, Hao-Chien Wang, Adel Khattab, Patricia Schonffeldt, Angelina Catanzariti, Ralf J.P. van der Valk, Maarten J.H.I. Beekman

5 May, 2022

NZ Respiratory Research Review Issue 200

Prognosis of Patients with COPD Not Eligible for Major Clinical Trials:

Yunus Çolak; Børge G Nordestgaard; Peter Lange; Jørgen Vestbo; Shoaib Afzal

18 April, 2022

NZ Respiratory Research Review Issue 198

Evaluating Prediction Models of Sleep Apnea From Smartphone-Recorded Sleep Breathing Sounds:

Sung-Woo Cho, MD; Sung Jae Jung, PhD; Jin Ho Shin, MS; et al

14 April, 2022

NZ Respiratory Research Review Issue 197

Early Th2 inflammation in the upper respiratory mucosa as a predictor of severe COVID-19 and modulation by early treatment with inhaled corticosteroids: a mechanistic analysis:

Jonathan R Baker, PhD Mahdi Mahdi, BSc Dan V Nicolau Jr, PhD Sanjay Ramakrishnan, MBBS Prof Peter J Barnes, FRS Jodie L Simpson, PhD et al.

7 April, 2022

NZ Respiratory Research Review Issue 200

Real-world opioid prescription to patients with serious, non-malignant, respiratory illnesses and chronic breathlessness:

Xinye Chen,Thomas Moran,Natasha Smallwood

5 April, 2022

NZ Respiratory Research Review Issue 198

Tuberculosis and COVID-19 co-infection: description of the global cohort:

The TB/COVID-19 Global Study Group. Corresponding author: Giovanni Battista Migliori

24 March, 2022

NZ Respiratory Research Review Issue 199